Live Chat

Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) Open High Low

Latest news

Frances Wang 2025 Feb 24, 16:00

Cava stock price: Cava Group news and forecast

Space.Xia 2025 Feb 24, 16:00

CBOT Grain Futures: Corn Shorts Surge 17,500 Contracts Ahead of USDA Report

Learn how to invest in tech stocks with high growth potential for long-term gains.
Vanessa L 2025 Feb 24, 09:00

How to Invest in Tech Stocks Amid Nvidia Stock Market Cap Swings

NVDA Stocks Shares
Alibaba’s $52B AI investment drives global interest in investing in AI and cloud computing.
Vanessa L 2025 Feb 24, 03:50

Alibaba's $52B AI Investment Reshapes AI Market

Stocks Shares Tech
Space.Xia 2025 Feb 23, 16:00

Will the Federal Reserve Be Trapped? U.S. Stocks May Face a 10% Sell-Off in the Second Half of the Year!

Tommy Yap 2025 Feb 23, 16:00

Morning Note: Zoom Q4 Earnings, Eurozone Inflation & Oil Prices

Morning Note Oil
Tommy Yap 2025 Feb 22, 16:00

Week Ahead: Australia Inflation and US Core PCE Price Index in Focus

Forex Indices
Why did stock market drop today due to Walmart's economic outlook.
Vanessa L 2025 Feb 21, 06:40

Why Did Stock Market Drop Today? Walmart’s Forecast Sparks Economic Concerns

Info

Spread

0.05

Spread (%)

0.6793 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

14:31 - 20:59

Monday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1279878016

Shares Outstanding

160184992

Earnings Date (Next)

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

EPS

-2.18

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot
Live Chat